Genovate Biotechnology Co. Ltd
4130StockTWO
25.80 ▼ 0.39%
12 juin 2026
4
Genovate Biotechnology Co. Ltd
25.80 ▼ 0.39%
12 juin 2026
4130StockTWO

01 / À propos

Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.

Arberion
Loading market data